Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

421
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
421
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.3K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

119
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dose-response association between metabolic syndrome component count and metabolic dysfunction-associated fatty liver disease, and independent graded association of visceral fat area: a cross-sectional study in a health-checkup population.

Frontiers in public health·2026
Same author

DSHformer: Locality-Sensitive Hash Attention and Prototype Alignment for Sensor-Based Human Activity Recognition.

Sensors (Basel, Switzerland)·2026
Same author

Near-Infrared-Driven Multiplexed, Self-Powered Photoelectrochemical Sensor for Portable and Reliable Detection of Steroid Estrogens.

Analytical chemistry·2026
Same author

Association of pan-immune inflammation value and systemic immune inflammation index with mortality in MASLD: A cohort study from NHANES 1999 to 2018.

Medicine·2026
Same author

Development of a clinical nomogram for predicting hemorrhagic rupture in renal angiomyolipoma and analysis of molecular correlates (<i>CD34</i>, <i>PPARG</i>, and <i>PTEN</i>).

Open medicine (Warsaw, Poland)·2026
Same author

Development of a core outcome set for traditional Chinese medicine for atrial fibrillation.

Frontiers in pharmacology·2026

Related Experiment Video

Updated: Apr 26, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K

Application of Artificial Intelligence In Drug-target Interactions Prediction: A Review.

Qian Liao1,2, Yu Zhang1, Ying Chu1

  • 1School of Computer and Information Engineering, Harbin University of Commerce, Harbin, China.

Npj Biomedical Innovations
|April 24, 2026
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) accelerates drug-target interaction (DTI) prediction, reducing costs and improving drug design screening. This review explores AI methods, challenges, and future directions for enhanced DTI prediction.

More Related Videos

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.8K

Related Experiment Videos

Last Updated: Apr 26, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.8K

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Artificial intelligence in drug discovery

Background:

  • Drug-target interaction (DTI) prediction is crucial but complex.
  • Traditional experimental methods are time-consuming and expensive.
  • Artificial intelligence (AI) offers a promising alternative for DTI prediction.

Purpose of the Study:

  • To review current AI-based approaches for DTI prediction.
  • To highlight the advantages of AI in accelerating drug discovery.
  • To identify challenges and suggest future research directions in AI for DTI.

Main Methods:

  • Review of machine learning and deep learning techniques applied to DTI.
  • Analysis of datasets and feature engineering for AI models.
  • Comparative assessment of different AI methodologies.

Main Results:

  • AI significantly enhances the speed and reduces the cost of DTI prediction.
  • AI methods enable efficient screening of potential drug candidates.
  • Various AI approaches show potential for accurate DTI prediction.

Conclusions:

  • AI-based DTI prediction is a rapidly advancing field with significant potential.
  • Addressing current challenges is key to unlocking the full capabilities of AI in drug discovery.
  • Future research should focus on novel AI architectures and data integration for improved DTI prediction.